Printer Friendly

DATASCOPE NET UP 15 PERCENT IN FIRST QUARTER

 MONTVALE, N.J., Oct. 21 / PRNewswire/ -- Datascope Corp. (NASDAQ: DSCP) reported a 15 percent rise in net earnings in the first quarter of fiscal 1994 to $2.44 million from $2.12 million in the comparable period last year, equivalent to $0.15 per share this year versus $0.13 per share last year. Consolidated sales in the first quarter were $38.1 million, 6 percent above the comparable period a year ago.
 The Company said that the favorable results are attributable to gains in its core business consisting of patient monitoring and cardiac assist. Sales growth of patient monitoring reflects continued strength of Datascope's PASSPORT(TM) portable bedside monitor line. Increased sales of intra-aortic balloon catheters and the System 95 intra-aortic balloon pump accounted for higher cardiac assist sales.
 The Company also announced the introduction of two major new products:
 On October 10, 1993 at the American Society of Anesthesiologist's Annual Meeting, the Company introduced the "point of view"(TM) critical care patient monitoring system which gives Datascope entry into an important market segment for advanced monitoring in operating rooms and post-anesthesia care units. The "point of view" system is scheduled to begin shipping in the third quarter of fiscal 1994.
 On November 8, 1993, at the American Heart Association's Scientific Sessions in Atlanta, the Company will introduce the System 97 "Small Wonder"(TM), a new compact intra-aortic balloon pump designed for use either at bedside or in transport. System 97 has the most advanced features and performance of any console balloon pump now being sold - yet has a footprint that is about 60 percent smaller. The market for small pumps accounts for two thirds of the total pump market.
 The Company also said it continues to pursue regulatory approval and registrations for VasoSeal(TM) in the United States and worldwide markets.
 Datascope Corp. manufactures proprietary products for clinical health care markets in interventional cardiology, anesthesiology and cardiovascular and vascular surgery.
 DATASCOPE CORP.
 SUMMARY OF OPERATING RESULTS (Unaudited)
 3 Months Ended 9/30/93 9/30/92
 Net Sales $38,100,000 $36,000,000
 Earnings Before Taxes 3,641,000 3,264,000
 Taxes 1,201,000 1,142,000
 Net Earnings $ 2,440,000 $2,122,000
 Earnings Per Share $0.15 $0.13
 Weighted Average Number of
 Common and Common
 Equivalent Shares
 Outstanding 16,133,000 16,285,000
 -0- 10/21/93
 /CONTACT: Murray Pitkowsky, senior vice president, 201-307-5504/
 (DSCP)


CO: Datascope Corp. ST: New Jersey IN: MTC SU: ERN

DH -- NY020 -- 5038 10/21/93 09:53 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 21, 1993
Words:424
Previous Article:COMPUTER IDENTICS ANNOUNCES THIRD QUARTER 1993 RESULTS
Next Article:WESTINGHOUSE AWARDED CONTRACTS WORTH NEARLY $250 MILLION BY LS POWER CORPORATION
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters